Clinical Trials Directory

Trials / Completed

CompletedNCT01471080

A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver

A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver:RFA Versus Laparoscopic Hepatectomy.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Southwest Hospital, China · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

In the past, the investigators often treated giant cavernous hemangiomas of the liver by hepatectomy.Recently RFA and laparoscopic hepatectomy are also available and could be applied to cure this disease.But we can't get a clear answer about their effectiveness and safety. Hence the investigators conduct this study to explore the effectiveness and efficiency of the these two methods and compare their short to mid-term outcomes.

Conditions

Interventions

TypeNameDescription
PROCEDURERFAusing RFA to treat cavernous hemangiomas
PROCEDUREhepatectomyusing hepatectomy to treat cavernous hemangiomas

Timeline

Start date
2011-11-01
Primary completion
2013-10-01
Completion
2014-01-01
First posted
2011-11-11
Last updated
2014-07-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01471080. Inclusion in this directory is not an endorsement.